DANESE, SILVIO
 Distribuzione geografica
Continente #
EU - Europa 2.129
NA - Nord America 1.844
AS - Asia 156
AF - Africa 16
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 9
SA - Sud America 8
Totale 4.174
Nazione #
US - Stati Uniti d'America 1.821
SE - Svezia 1.422
FI - Finlandia 318
DE - Germania 107
IT - Italia 103
GB - Regno Unito 50
IE - Irlanda 41
CN - Cina 30
IN - India 30
JP - Giappone 24
SG - Singapore 24
CA - Canada 22
FR - Francia 22
NL - Olanda 18
IR - Iran 14
ES - Italia 12
AU - Australia 10
PL - Polonia 10
EU - Europa 9
CH - Svizzera 7
DZ - Algeria 7
HK - Hong Kong 6
KR - Corea 6
EG - Egitto 4
MA - Marocco 4
SA - Arabia Saudita 4
UA - Ucraina 4
BE - Belgio 3
DK - Danimarca 3
KW - Kuwait 3
AR - Argentina 2
BR - Brasile 2
HR - Croazia 2
ID - Indonesia 2
IL - Israele 2
JO - Giordania 2
KZ - Kazakistan 2
NZ - Nuova Zelanda 2
PK - Pakistan 2
RO - Romania 2
SI - Slovenia 2
TW - Taiwan 2
VE - Venezuela 2
CL - Cile 1
CO - Colombia 1
CU - Cuba 1
CZ - Repubblica Ceca 1
HU - Ungheria 1
ME - Montenegro 1
MY - Malesia 1
PH - Filippine 1
TR - Turchia 1
ZA - Sudafrica 1
Totale 4.174
Città #
Lawrence 702
Princeton 700
Helsinki 315
New York 157
Dublin 39
Ashburn 37
Borås 29
Shanghai 23
Milan 20
Singapore 19
London 18
Delhi 16
Seattle 13
Sendagaya 11
Saint Louis 10
Los Angeles 9
Bologna 7
Mountain View 7
Nottingham 7
St Louis 7
Versailles 7
New Hyde Park 6
Warsaw 6
Pune 5
Amsterdam 4
Baltimore 4
Cairo 4
Hyderabad 4
Maidstone 4
Paris 4
Rome 4
Sydney 4
Adelaide 3
Berlin 3
Catania 3
Cherchell 3
Columbus 3
Dammam 3
Dongjak-gu 3
Harrisburg 3
Inverigo 3
Kuwait City 3
Lappeenranta 3
Monza 3
Redwood City 3
Rockville 3
San Giovanni Rotondo 3
Spokane 3
Sunnyvale 3
Toronto 3
Vigo 3
Ziefen 3
Zurich 3
Amman 2
Astana 2
Barcelona 2
Barking 2
Barquisimeto 2
Beijing 2
Benevento 2
Blida 2
Boardman 2
Buenos Aires 2
Buffalo 2
Camogli 2
Cellatica 2
Cergy 2
Chandigarh 2
Collazzone 2
Denpasar 2
Duino 2
Faisalabad 2
Frankfurt am Main 2
Hangzhou 2
Honjocho 2
Ibaraki 2
Jerusalem 2
Jongno-gu 2
Kawasaki 2
Kolding 2
Laredo 2
Limena 2
Linköping 2
Ljubljana 2
Lucknow 2
Madrid 2
Manchester 2
Massafra 2
Melbourne 2
Naaldwijk 2
Naples 2
Niigata 2
Northborough 2
Nuremberg 2
Orlando 2
Osaka 2
Palermo 2
Pamplona 2
Quiliano 2
Rabat 2
Totale 2.359
Nome #
VAGUS NERVE STIMULATION REDUCES DISEASE ACTIVITY AND MODULATES SERUM AND AUTONOMIC BIOMARKERS IN BIOLOGICREFRACTORY CROHN'S DISEASE 55
Inflammation and coagulation in inflammatory bowel disease: The clot thickens 46
New Drug Delivery Systems in Inflammatory Bowel Disease: MMX (TM) and Tailored Delivery to the Gut 46
Crohn's disease 40
Prospective comparison of computed tomography enterography and magnetic resonance enterography for assessment of disease activity and complications in ileocolonic Crohn's disease 26
Involvement of CD40-CD40 Ligand in Uncomplicated and Refractory Celiac Disease 24
Critical role of the CD40-CD40-ligand pathway in regulating mucosal inflammation-driven angiogenesis in inflammatory bowel disease 20
The Role of the Multidisciplinary Health Care Team in the Management of Patients with Systemic Sclerosis 19
Endoscopic Vacuum Therapy (EVT) versus Self-Expandable Metal Stent (SEMS) for Anastomotic Leaks after Upper Gastrointestinal Surgery: Systematic Review and Meta-Analysis 18
Budesonide : teaching an old dog new tricks for inflammatory bowel disease treatment 17
Endoscopic vacuum therapy versus self-expandable metal stent for treatment of anastomotic leaks < 30 mm following oncologic Ivor-Lewis esophagectomy: a matched case-control study 16
JAK selectivity for inflammatory bowel disease treatment: does it clinically matter? 16
A snapshot of the ongoing clinical research on COVID-19 16
A Prospective Comparison Between Computerized Tomography (CT) and Magnetic Resonance (MR) in Ileo-Colonic Crohn's Disease: A Single-Center Experience 15
Publisher Correction: Crohn's disease 15
Darvadstrocel for the treatment of patients with perianal fistulas in Crohn's disease 15
WallFlex colonic stent placement for management of malignant colonic obstruction : a prospective study at two centers 15
Ustekinumab in the management of Crohn's disease: Expert opinion 15
JAK inhibition using tofacitinib for inflammatory bowel disease treatment: a hub for multiple inflammatory cytokines 15
A liophylized and inactivated colture of Lactobacillus acidophilus increases Helicobacter pylori eradication rate 15
Colitis, microbiota and colon cancer: an infernal triangle 14
LeMann Index Assessment Overtime in Crohn's Disease Patients Treated With Anti TNFs: A Pilot Observational Cohort Study 14
Inflammatory bowel disease (IBD) position statement of the Italian Society of Colorectal Surgery (SICCR): general principles of IBD management 14
y ANTIBODIES TO INFLIXIMAB IN PATIENTS TREATED WITH EITHER THE REFERENCE BIOLOGIC OR THE BIOSIMILAR CT-P13 SHOW IDENTICAL REACTIVITY TOWARDS BIOSIMILARS CT-P13 AND SB2 IN INFLAMMATORY BOWEL DISEASE 14
E-health in inflammatory bowel diseases: More challenges than opportunities? 14
Inflammatory Bowel Disease Care in the COVID-19 Pandemic Era: The Humanitas, Milan, Experience 14
Outcomes of COVID-19 in 79 patients with IBD in Italy: an IG-IBD study 14
Upadacitinib as induction and maintenance therapy for moderately to severely active ulcerative colitis: results from three phase 3, multicentre, double-blind, randomised trials 13
LONG-TERM SAFETY OF VEDOLIZUMAB IN ULCERATIVE COLITIS AND CROHN'S DISEASE: FINAL RESULTS FROM THE GEMINI LTS STUDY 13
Long-term Efficacy and Safety of Stem Cell Therapy (Cx601) for Complex Perianal Fistulas in Patients With Crohn's Disease 13
JAK selectivity: more precision less troubles 13
JAK inhibitors: Novel developments in management of ulcerative colitis 13
Application of Artificial Intelligence to Gastroenterology and Hepatology 13
Glycosylation of Immunoglobulin G Associates With Clinical Features of Inflammatory Bowel Diseases 13
H. pylori gastric infection in rheumatic diseases 13
INTENSIVE DIAGNOSTIC FOLLOW-UP AFTER TREATMENT OF PRIMARY BREAST-CANCER - A RANDOMIZED TRIAL 13
Colon Staining Efficacy of Methylene Blue MMx (R) 25 mg Modified Release Tablets, Administered As Single Ascending Oral Doses of 150 and 200 mg in Outpatients Colonoscopy 13
Ulcerative Colitis 13
A PROLONGED FOLLOW-UP ON THE EFFICACY AND SAFETY OF INFLIXIMAB BIOSIMILAR CT-P13 IN IBD ACROSS ITALY: THE PROSIT COHORT 12
A PROSPECTIVE, SINGLE CENTER STUDY OF ENDOSCOPIC SUBMUCOSAL DISSECTION OF RECTAL LST LESIONS > 3 CM BY USING AN INNOVATIVE CONCEPT OF INJECTING AND CUTTING: THE WATER-JET HYBRID-KNIFE (ESD-H) 12
A Prospective Comparison Between 1.5t Magnetic Resonance and 3t Magnetic Resonance in Ileo-Colonic Crohn's Disease: A Single Center Experience 12
PRESENTATION AND SURGICAL INTERVENTIONS FOR CROHN'S DISEASE WITH PERIANAL FISTULA IN THE BIOLOGICS ERA: RESULTS FROM A MULTICENTRE STUDY 12
Activated platelets are the source of elevated levels of soluble CD40 ligand in the circulation of inflammatory bowel disease patients 12
The PROSIT-BIO Cohort of the IG-IBD: A Prospective Observational Study of Patients With Inflammatory Bowel Disease Treated With Infliximab BioSimilars 12
Activation of the VEGFC/VEGFR3 Pathway Induces Tumor Immune Escape in Colorectal Cancer 12
Fibroblast Growth Factor 19 modulates intestinal microbiota and inflammation in presence of Farnesoid X Receptor 12
A Practical Guide for Faecal Calprotectin Measurement: Myths and Realities 12
Helicobacter pylori CagA-positive strains affect oxygen free radicals generation by gastric mucosa 12
JAK or GUT Selectivity: Tipping the Balance for Efficacy and Safety in Ulcerative Colitis 12
JAK inhibition in inflammatory bowel disease 12
Correction to: Inflammatory bowel disease (IBD) position statement of the Italian Society of Colorectal Surgery (SICCR): general principles of IBD management 11
The VEGF-VEGF receptor (VEGF-R) pathway is up-regulated and mediates mucosal angiogenesis in human and experimental inflammatory bowel disease (IBD) 11
The effects of vagus nerve stimulation in biologic-refractory Crohn's disease: A prospective clinical trial 11
Clinical Utility of the LeMann Index and Rutgeerts Score to Predict Postoperative Course of Crohn's Disease: A Retrospective Single-Center Cohort Study 11
Ulcerative Colitis and Crohn's Disease Have Similar Burden and Goals for Treatment 11
Vaccination recommendations for the adult immunosuppressed patient: A systematic review and comprehensive field synopsis 11
Janus kinase inhibitors for the treatment of inflammatory bowel diseases: developments from phase I and phase II clinical trials 11
Evaluation of the Cross-reactivity of Antidrug Antibodies to CT-P13 and Infliximab Reference Product (Remicade): An Analysis Using Immunoassays Tagged with Both Agents 11
MULTICENTRE COHORT STUDY TO EVALUATE THE NEED FOR RE-INTERVENTION FOLLOWING MULTIMODAL TREATMENT IN CROHNS DISEASE WITH PERIANAL FISTULA 11
Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease 11
Comparative accuracy of ferritin, transferrin saturation and soluble transferrin receptor for the diagnosis of iron deficiency in inflammatory bowel disease 11
Thrombotic complications in inflammatory bowel disease: A multifactorial etiology 11
5-Fluorouracil, epirubicin and cyclophosphamide versus epirubicin and paclitaxel in node-positive early breast cancer: a phase-III randomized GONO-MIG5 trial 11
Association between Helicobacter pylori cytotoxic type I strains and migraine with aura 11
Dysregulated intracellular redox equilibrium in intestinal lamina propria T cells (LPT) contributes to mucosal inflammation 11
Cytapheresis in inflammatory bowel diseases: Current evidence and perspectives 11
The biosimilar road in inflammatory bowel disease: The right way? 11
A PROSPECTIVE MULTICENTER OBSERVATIONAL COHORT STUDY ASSESSING THE EFFECTIVENESS OF BUDESONIDE MMX (R) FOR MILD-TO-MODERATE ULCERATIVE COLITIS 11
Ozanimod induction therapy for patients with moderate to severe Crohn's disease: a single-arm, phase 2, prospective observer-blinded endpoint study 11
The role of diet and lifestyle in early-onset colorectal cancer: A systematic review 11
Endoscopic internal drainage versus endoscopic vacuum therapy for upper gastrointestinal leaks: what's the real deal? 10
Urokinase Receptor Promotes Skin Tumor Formation by Preventing Epithelial Cell Activation of Notch1 10
Bacterial sensor triggering receptor expressed on myeloid cells-2 regulates the mucosal inflammatory response 10
A prospective multi-centre observational cohort study assessing the effectiveness of Budesonide MMX (R) for mild-to-moderate ulcerative colitis 10
Enhanced platelet adhesion induces angiogenesis in the IBD microcirculation 10
Helicobacter pylori CagA positive strains determine oxidative DNA damage in gastric cells 10
Head-to-head trials in inflammatory bowel disease: past, present and future 10
Risk factor analysis for therapy related adverse events and infections in elder patients with Inflammatory Bowel Disease; An analysis from the IG-IBD aged study 10
BOWEL ULTRASOUND IS ACCURATE IN ASSESSING DISEASE ACTIVITY IN ULCERATIVE COLITIS 10
Infliximab in Steroid-Dependent Ulcerative Colitis: Efficacy and Predictors of Clinical and Endoscopic Remission 10
New targeted therapies such as anti-adhesion molecules, anti-IL-12/23 and anti-Janus kinases are looking toward a more effective treatment of inflammatory bowel disease 10
Has IBD specialists' awareness of biosimilar monoclonal antibodies changed? Results from a survey amongst ECCO members 10
MULTICENTRE ECCO COLLABORATIVE GROUP STUDY TO EVALUATE THE NEED FOR REINTERVENTION FOLLOWING MULTIMODAL TREATMENT IN CROHN'S DISEASE WITH PERIANAL FISTULA 10
SELF-EXPANDABLE BIODEGRADABLE STENT IN THE MANAGEMENT OF REFRACTORY BENIGN COLORECTAL STRICTURES: PRELIMINARY RESULTS FROM A PILOT STUDY 10
Value of Preoperative Magnetic Resonance Enterography to Predict Surgical Findings and to Guide Decisions in Crohn's Disease: A Prospective Study 10
SWITCHING FROM INFLIXIMAB ORIGINATOR TO CT-P13 IS NOT RELATED TO INCREASED IMMUNOGENICITY IN IBD PATIENTS: A PROSPECTIVE CASE-CONTROL STUDY 10
Unique role of junctional adhesion molecule-A in maintaining mucosal homeostasis in inflammatory bowel disease 10
Development of Red Flags for Early Referral of Adults With Symptoms and Signs Suggestive of Crohn's Disease: An IOIBD Initiative 10
Views of patients with inflammatory bowel disease on the COVID-19 pandemic: a global survey 10
Galectin-4 Controls Intestinal Inflammation by Selective Regulation of Peripheral and Mucosal T Cell Apoptosis and Cell Cycle 10
ICON2: randomised trial of single-agent carboplatin against three-drug combination of CAP (cyclophosphamide, doxorubicin, and cisplatin) in women with ovarian cancer 10
Thrombopoietin serum levels in patients with inflammatory bowel disease with and without previous thromboembolic events 10
Is cytotoxic-associated gene A-positive Helicobacter pylori important? 10
Adalimumab in Crohn's disease : tips and tricks after 5 years of clinical experience 10
Ulcerative Colitis: A Cinderella Story 10
Review article: potential therapeutic applications and mechanisms of action of heparin in inflammatory bowel disease 10
A Surface Plasmon Resonance-based assay to measure serum concentrations of therapeutic antibodies and anti-drug antibodies 10
Colonic diverticular disease 10
Safety of Janus Kinase Inhibitors in Patients With Inflammatory Bowel Diseases or Other Immune-mediated Diseases: A Systematic Review and Meta-Analysis 10
Preventing Diverticulitis Recurrence by Selecting the Right Therapy for a Complex Disease 10
Totale 1.369
Categoria #
all - tutte 107.147
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 107.147


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211 0 0 0 1 0 0 0 0 0 0 0 0
2021/2022961 0 0 0 810 16 17 7 5 23 23 15 45
2022/20233.362 1.824 645 74 12 14 363 54 136 179 20 13 28
2023/2024576 31 38 62 52 54 196 26 70 2 45 0 0
Totale 4.902